859 related articles for article (PubMed ID: 16416395)
21. L-type voltage-dependent calcium channels as therapeutic targets for neurodegenerative diseases.
Yagami T; Kohma H; Yamamoto Y
Curr Med Chem; 2012; 19(28):4816-27. PubMed ID: 22834820
[TBL] [Abstract][Full Text] [Related]
22. Unfolded Protein Response and Macroautophagy in Alzheimer's, Parkinson's and Prion Diseases.
Milisav I; Šuput D; Ribarič S
Molecules; 2015 Dec; 20(12):22718-56. PubMed ID: 26694349
[TBL] [Abstract][Full Text] [Related]
23. Neurodegenerative diseases: The immunological perspective.
Molteni M; Rossetti C
J Neuroimmunol; 2017 Dec; 313():109-115. PubMed ID: 29153601
[TBL] [Abstract][Full Text] [Related]
24. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.
Venneti S; Lopresti BJ; Wiley CA
Prog Neurobiol; 2006 Dec; 80(6):308-22. PubMed ID: 17156911
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of IL-34 Unveils Tissue-Selectivity and Is Sufficient to Reduce Microglial Proliferation in a Model of Chronic Neurodegeneration.
Obst J; Simon E; Martin-Estebane M; Pipi E; Barkwill LM; Gonzalez-Rivera I; Buchanan F; Prescott AR; Faust D; Fox S; Brownlees J; Taylor D; Perry VH; Nuthall H; Atkinson PJ; Karran E; Routledge C; Gomez-Nicola D
Front Immunol; 2020; 11():579000. PubMed ID: 33162994
[TBL] [Abstract][Full Text] [Related]
26. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
27. Possible roles of microglial cells for neurotoxicity in clinical neurodegenerative diseases and experimental animal models.
Sugama S; Takenouchi T; Cho BP; Joh TH; Hashimoto M; Kitani H
Inflamm Allergy Drug Targets; 2009 Sep; 8(4):277-84. PubMed ID: 19754411
[TBL] [Abstract][Full Text] [Related]
28. Microglia in prion diseases.
Aguzzi A; Zhu C
J Clin Invest; 2017 Sep; 127(9):3230-3239. PubMed ID: 28714865
[TBL] [Abstract][Full Text] [Related]
29. Neurodegeneration and inflammation in Parkinson's disease.
Phani S; Loike JD; Przedborski S
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S207-9. PubMed ID: 22166436
[TBL] [Abstract][Full Text] [Related]
30. In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's disease.
Iannaccone S; Cerami C; Alessio M; Garibotto V; Panzacchi A; Olivieri S; Gelsomino G; Moresco RM; Perani D
Parkinsonism Relat Disord; 2013 Jan; 19(1):47-52. PubMed ID: 22841687
[TBL] [Abstract][Full Text] [Related]
31. Stages of granulovacuolar degeneration: their relation to Alzheimer's disease and chronic stress response.
Thal DR; Del Tredici K; Ludolph AC; Hoozemans JJ; Rozemuller AJ; Braak H; Knippschild U
Acta Neuropathol; 2011 Nov; 122(5):577-89. PubMed ID: 21935637
[TBL] [Abstract][Full Text] [Related]
32. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
33. Neuroendocrinology of neurodegenerative diseases. Insights from transgenic mouse models.
González De Aguilar JL; René F; Dupuis L; Loeffler JP
Neuroendocrinology; 2003 Nov; 78(5):244-52. PubMed ID: 14657605
[TBL] [Abstract][Full Text] [Related]
34. Copper-dependent oxidative stress and neurodegeneration.
Rotilio G; Carrì MT; Rossi L; Ciriolo MR
IUBMB Life; 2000; 50(4-5):309-14. PubMed ID: 11327325
[TBL] [Abstract][Full Text] [Related]
35. PD-1 deficiency is not sufficient to induce myeloid mobilization to the brain or alter the inflammatory profile during chronic neurodegeneration.
Obst J; Mancuso R; Simon E; Gomez-Nicola D
Brain Behav Immun; 2018 Oct; 73():708-716. PubMed ID: 30086399
[TBL] [Abstract][Full Text] [Related]
36. [Microglia: function in the pathological state].
Nakajima K; Kohsaka S
No To Shinkei; 1998 Jan; 50(1):5-16. PubMed ID: 9493193
[No Abstract] [Full Text] [Related]
37. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
Barnham KJ; Bush AI
Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
[TBL] [Abstract][Full Text] [Related]
38. POSCAbilities: The Application of the Prion Organotypic Slice Culture Assay to Neurodegenerative Disease Research.
Pineau H; Sim V
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32698402
[TBL] [Abstract][Full Text] [Related]
39. Cholesterol involvement in the pathogenesis of neurodegenerative diseases.
Liu JP; Tang Y; Zhou S; Toh BH; McLean C; Li H
Mol Cell Neurosci; 2010 Jan; 43(1):33-42. PubMed ID: 19660552
[TBL] [Abstract][Full Text] [Related]
40. Effect of Microglial Inflammation in Prion Disease.
Ano Y; Sakudo A; Onodera T
Curr Issues Mol Biol; 2020; 36():1-12. PubMed ID: 31486773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
